Compounds > 1,3-dipropyl-8-cyclopentylxanthine

1,3-dipropyl-8-cyclopentylxanthine and morphine

1,3-dipropyl-8-cyclopentylxanthine has been researched along with morphine in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (25.00)	18.2507
2000's	6 (50.00)	29.6817
2010's	3 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hope, W; Rose'Meyer, RB; White, PJ	1
Coupar, IM; Hancock, DL	1
Naghipour, B; Roushan-zamir, F; Shafaghi, B; Zarrindast, MR	1
Fiorillo, CD; Williams, JT	1
Coupar, IM; Tran, BL	1
Christie, MJ; Hack, SP; Vaughan, CW	1
DeLander, GE; Fredholm, BB; Halldner, L; Hao, JX; Lövdahl, C; Wiesenfeld-Hallin, Z; Wu, WP; Xu, XJ	1
Cho, SK; Han, SM; Hwang, GS; Hwang, JH	1
Bagley, EE; Chieng, BC; Christie, MJ; Hack, SP	1
Cidral-Filho, FJ; Martins, DF; Mazzardo-Martins, L; Santos, AR; Stramosk, J	1
Akbarian, R; Moezi, L; Niknahad, H; Shafaroodi, H	1
Fathollahi, Y; Sadegh, M	1

Other Studies

12 other study(ies) available for 1,3-dipropyl-8-cyclopentylxanthine and morphine

Article	Year
The role of adenosine in the hypotensive actions of morphine. European journal of pharmacology, 1995, Nov-24, Volume: 286, Issue:3 Topics: Adenosine; Animals; Blood Pressure; Female; Guanethidine; Morphine; Narcotics; Rats; Rats, Wistar; Receptors, Purinergic P1; Theobromine; Theophylline; Xanthines	1995
Studies investigating the possible involvement of adenosine in the antisecretory action of morphine. General pharmacology, 1997, Volume: 28, Issue:5 Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Decerebrate State; Female; Intestinal Mucosa; Jejunum; Male; Morphine; Naloxone; Narcotic Antagonists; Norepinephrine; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Reserpine; Sympatholytics; Vasoactive Intestinal Peptide; Xanthines	1997
Effects of adenosine receptor agents on the expression of morphine withdrawal in mice. European journal of pharmacology, 1999, Mar-12, Volume: 369, Issue:1 Topics: Adenosine; Analysis of Variance; Animals; Behavior, Animal; Diarrhea; Male; Mice; Mice, Inbred Strains; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Substance Withdrawal Syndrome; Theobromine; Xanthines	1999
Selective inhibition by adenosine of mGluR IPSPs in dopamine neurons after cocaine treatment. Journal of neurophysiology, 2000, Volume: 83, Issue:3 Topics: Adenosine; Amphetamine; Animals; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Electrophysiology; Excitatory Postsynaptic Potentials; Male; Morphine; Narcotics; Neurons; Patch-Clamp Techniques; Rats; Rats, Wistar; Receptors, GABA-A; Receptors, GABA-B; Receptors, Metabotropic Glutamate; Synapses; Xanthines	2000
Withdrawal and bidirectional cross-withdrawal responses in rats treated with adenosine agonists and morphine. Life sciences, 2001, Jul-06, Volume: 69, Issue:7 Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Behavior, Animal; Female; Injections, Subcutaneous; Male; Morphine; Morphine Dependence; Muscle Contraction; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Theobromine; Xanthines	2001
Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro. Neuropharmacology, 2003, Volume: 45, Issue:5 Topics: Action Potentials; Adenosine; Affinity Labels; Animals; Colforsin; Cyclic AMP; Dipyridamole; Dose-Response Relationship, Drug; Drug Interactions; Enkephalins; Enzyme Inhibitors; gamma-Aminobutyric Acid; In Vitro Techniques; Isoquinolines; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Neural Inhibition; Neurons; Patch-Clamp Techniques; Periaqueductal Gray; Probenecid; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Substance Withdrawal Syndrome; Sulfonamides; Synaptic Transmission; Thioinosine; Time Factors; Uricosuric Agents; Vasodilator Agents; Xanthines	2003
Increased nociceptive response in mice lacking the adenosine A1 receptor. Pain, 2005, Volume: 113, Issue:3 Topics: Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Analgesics, Opioid; Analysis of Variance; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Female; Functional Laterality; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morphine; Nociceptors; Pain Measurement; Photochemistry; Protein Binding; Radioligand Assay; Rats; Reaction Time; Receptor, Adenosine A1; Sciatica; Statistics, Nonparametric; Time Factors; Xanthines	2005
Morphine can enhance the antiallodynic effect of intrathecal R-PIA in rats with nerve ligation injury. Anesthesia and analgesia, 2005, Volume: 100, Issue:2 Topics: Adenosine A1 Receptor Agonists; Analgesics, Opioid; Animals; Circadian Rhythm; Dose-Response Relationship, Drug; Drug Synergism; Injections, Spinal; Ligation; Male; Morphine; Naloxone; Narcotic Antagonists; Pain; Pain Measurement; Peripheral Nervous System Diseases; Phenylisopropyladenosine; Rats; Rats, Sprague-Dawley; Xanthines	2005
Induction of delta-opioid receptor function in the midbrain after chronic morphine treatment. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2005, Mar-23, Volume: 25, Issue:12 Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Arrestins; beta-Arrestin 2; beta-Arrestins; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Electric Stimulation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Excitatory Amino Acid Antagonists; G Protein-Coupled Inwardly-Rectifying Potassium Channels; gamma-Aminobutyric Acid; Glycine Agents; In Vitro Techniques; Isoquinolines; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Knockout; Morphine; Narcotic Antagonists; Narcotics; Neurons; Oligopeptides; Patch-Clamp Techniques; Periaqueductal Gray; Protein Kinase Inhibitors; Receptors, Opioid, delta; Receptors, Opioid, mu; Strychnine; Sulfonamides; Synaptic Transmission; Time Factors; Xanthines	2005
Ankle joint mobilization affects postoperative pain through peripheral and central adenosine A1 receptors. Physical therapy, 2013, Volume: 93, Issue:3 Topics: Adenosine; Analysis of Variance; Animals; Ankle Joint; Caffeine; Clonidine; Disease Models, Animal; Fenclonine; Hyperalgesia; Male; Mice; Morphine; Pain, Postoperative; Receptor, Adenosine A1; Xanthines; Yohimbine	2013
The interaction of adenosine and morphine on pentylenetetrazole-induced seizure threshold in mice. Neuropharmacology, 2013, Volume: 72 Topics: Adenosine; Animals; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Male; Mice; Morphine; Naltrexone; Narcotic Antagonists; Pentylenetetrazole; Seizures; Xanthines	2013
Repetitive systemic morphine alters activity-dependent plasticity of Schaffer-collateral-CA1 pyramidal cell synapses: involvement of adenosine A1 receptors and adenosine deaminase. Journal of neuroscience research, 2014, Volume: 92, Issue:10 Topics: Adenine; Adenosine A1 Receptor Antagonists; Adenosine Deaminase; Animals; Biophysical Phenomena; CA1 Region, Hippocampal; Drug Administration Schedule; Electric Stimulation; Enzyme Inhibitors; In Vitro Techniques; Male; Morphine; Narcotics; Nerve Fibers; Nerve Net; Neuronal Plasticity; Rats; Rats, Wistar; Receptor, Adenosine A1; Xanthines	2014